Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

Neuralink, a leader in the fledgling field of brain implants, is hurting the industry's efforts to develop useful medical ...

ATLATL, one of China’s leading biotech incubators, is seeking to bridge East-West innovation and tap into China's rapidly ...

When Americans make decisions — like whether to pack an umbrella or prepare for a hurricane — they rely on clear, timely, and ...

Over the past few years, many researchers have tried to test large language models’ medical capabilities using questions from the U.S. medical licensure exam, or by feeding them clinical vignettes ...

In 2026, disability advocates want expanded access to primary and emergency care — and influence new debates around genetic ...

Babies who don’t get their first round of vaccines on time at 2 months of age are much less likely to get vaccinated against ...

What to watch out for in 2026, as the health care industry gears up for a battle over how clinical AI should get paid for.

As a public health scientist, I have learned that firm prescriptions rarely capture life’s complexity,” Robert M. Kaplan ...

It has been a tough year for medicine. The U.S. research enterprise has been scrambled by a series of political decisions ...

Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...

NIH Director Jay Bhattacharya told a podcaster that DEI-related grants restored under a court order won't be renewed in 2026 ...